Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Making an informed choice: Which breast reconstruction type has the lowest complication rate?

Hangge PT, Jogerst K, Mohsen A, Kosiorek H, Cronin PA, Stucky CH, Wasif N, Gray RJ, Rebecca AM, Casey WJ 3rd, Pockaj BA.

Am J Surg. 2019 Sep 27. pii: S0002-9610(19)30356-3. doi: 10.1016/j.amjsurg.2019.09.033. [Epub ahead of print]

PMID:
31606126
2.

Implementation of an Enhanced Recovery After Surgery (ERAS) Program is Associated with Improved Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Webb C, Day R, Velazco CS, Pockaj BA, Gray RJ, Stucky CC, Young-Fadok T, Wasif N.

Ann Surg Oncol. 2019 Oct 11. doi: 10.1245/s10434-019-07900-z. [Epub ahead of print]

PMID:
31605328
3.

Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast.

Vranic S, Senarathne W, Stafford P, Poorman K, Pockaj BA, Gatalica Z.

Appl Immunohistochem Mol Morphol. 2019 Sep 11. doi: 10.1097/PAI.0000000000000808. [Epub ahead of print]

PMID:
31517642
4.

Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival.

Ertz-Archambault NM, Rogoff LB, Kosiorek HE, Ernst BJ, Anderson KS, Pockaj BA, Gray RJ, Northfelt DW.

Support Care Cancer. 2019 Aug 11. doi: 10.1007/s00520-019-05013-7. [Epub ahead of print]

PMID:
31402403
5.

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.

McDonald BR, Contente-Cuomo T, Sammut SJ, Odenheimer-Bergman A, Ernst B, Perdigones N, Chin SF, Farooq M, Mejia R, Cronin PA, Anderson KS, Kosiorek HE, Northfelt DW, McCullough AE, Patel BK, Weitzel JN, Slavin TP, Caldas C, Pockaj BA, Murtaza M.

Sci Transl Med. 2019 Aug 7;11(504). pii: eaax7392. doi: 10.1126/scitranslmed.aax7392.

PMID:
31391323
6.

Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer.

Wasif N, Neville M, Gray R, Cronin P, Pockaj BA.

J Am Coll Surg. 2019 Jul;229(1):30-36.e1. doi: 10.1016/j.jamcollsurg.2019.03.013. Epub 2019 Mar 29.

PMID:
30930100
7.

Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy.

Sheaffer WW, Gray RJ, Wasif N, Stucky CC, Cronin PA, Kosiorek HE, Basu A, Pizzitola VJ, Patel B, Giurescu ME, Lorans R, McCullough AE, Ocal IT, Pockaj BA.

Am J Surg. 2019 Jun;217(6):1025-1029. doi: 10.1016/j.amjsurg.2018.12.069. Epub 2019 Feb 23.

PMID:
30879795
8.

Microsatellitosis in Patients with Melanoma.

Karakousis GC, Gimotty PA, Leong SP, Pockaj BA, White RL, O'Donoghue C, Sinnamon AJ, Bartlett EK, Dueck AC, Gould Rothberg BE, Messina JL, Vetto JT, Sondak VK, Schneebaum S, Kashani-Sabet M, Han D, Faries MB, Zager JS; with the Sentinel Lymph Node Working Group.

Ann Surg Oncol. 2019 Jan;26(1):33-41. doi: 10.1245/s10434-018-7006-4. Epub 2018 Nov 12.

PMID:
30421045
9.

Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.

Hanna AN, Sinnamon AJ, Roses RE, Kelz RR, Elder DE, Xu X, Pockaj BA, Zager JS, Fraker DL, Karakousis GC.

J Am Acad Dermatol. 2019 Feb;80(2):433-440. doi: 10.1016/j.jaad.2018.08.022. Epub 2018 Aug 27.

PMID:
30165160
10.

Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy.

Hilal T, Covington M, Kosiorek HE, Zwart C, Ocal IT, Pockaj BA, Northfelt DW, Patel BK.

Breast J. 2018 Nov;24(6):1010-1014. doi: 10.1111/tbj.13101. Epub 2018 Jul 31.

PMID:
30066421
11.

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers.

Barrett MT, Lenkiewicz E, Malasi S, Basu A, Yearley JH, Annamalai L, McCullough AE, Kosiorek HE, Narang P, Wilson Sayres MA, Chen M, Anderson KS, Pockaj BA.

Breast Cancer Res. 2018 Jul 11;20(1):71. doi: 10.1186/s13058-018-1004-0.

12.

The diagnostic value of splenectomy in patients without a definitive preoperative diagnosis.

Hangge PT, Sheaffer WW, Neville M, Wasif N, Gray RJ, Pockaj BA, Stucky CH.

Am J Surg. 2019 Jan;217(1):78-82. doi: 10.1016/j.amjsurg.2018.05.020. Epub 2018 May 29.

PMID:
29880389
13.

Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients.

Sims JR, Grotz TE, Pockaj BA, Joseph RW, Foote RL, Otley CC, Weaver AL, Jakub JW, Price DL.

Surg Oncol. 2018 Mar;27(1):11-17. doi: 10.1016/j.suronc.2017.10.005. Epub 2017 Oct 26.

PMID:
29549898
14.

Does Improved Mortality at Low- and Medium-Volume Hospitals Lead to Attenuation of the Volume to Outcomes Relationship for Major Visceral Surgery?

Wasif N, Etzioni DA, Habermann EB, Mathur A, Pockaj BA, Gray RJ, Chang YH.

J Am Coll Surg. 2018 Jul;227(1):85-93.e9. doi: 10.1016/j.jamcollsurg.2018.02.011. Epub 2018 Mar 7.

PMID:
29524663
15.

Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.

Patel BK, Hilal T, Covington M, Zhang N, Kosiorek HE, Lobbes M, Northfelt DW, Pockaj BA.

Ann Surg Oncol. 2018 May;25(5):1350-1356. doi: 10.1245/s10434-018-6413-x. Epub 2018 Mar 7.

PMID:
29516362
16.

Stratifying SLN incidence in intermediate thickness melanoma patients.

Chang JM, Kosiorek HE, Dueck AC, Leong SPL, Vetto JT, White RL, Avisar E, Sondak VK, Messina JL, Zager JS, Garberoglio C, Kashani-Sabet M, Pockaj BA.

Am J Surg. 2018 Apr;215(4):699-706. doi: 10.1016/j.amjsurg.2017.12.009. Epub 2017 Dec 14.

17.

Racial and Socioeconomic Differences in the Use of High-Volume Commission on Cancer-Accredited Hospitals for Cancer Surgery in the United States.

Wasif N, Etzioni D, Habermann EB, Mathur A, Pockaj BA, Gray RJ, Chang YH.

Ann Surg Oncol. 2018 May;25(5):1116-1125. doi: 10.1245/s10434-018-6374-0. Epub 2018 Feb 15.

PMID:
29450752
18.

Choosing wisely after publication of level I evidence in breast cancer radiotherapy.

Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW.

Breast Cancer (Dove Med Press). 2018 Feb 9;10:31-37. doi: 10.2147/BCTT.S153117. eCollection 2018.

19.

Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.

Patel BK, Ranjbar S, Wu T, Pockaj BA, Li J, Zhang N, Lobbes M, Zhang B, Mitchell JR.

Eur J Radiol. 2018 Jan;98:207-213. doi: 10.1016/j.ejrad.2017.11.024. Epub 2017 Dec 5.

PMID:
29279165
20.

The Future of Contrast-Enhanced Mammography.

Covington MF, Pizzitola VJ, Lorans R, Pockaj BA, Northfelt DW, Appleton CM, Patel BK.

AJR Am J Roentgenol. 2018 Feb;210(2):292-300. doi: 10.2214/AJR.17.18749. Epub 2017 Oct 24. Review.

PMID:
29064748
21.

Discussion of: "The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review".

Chang JM, Kosiorek HE, Wasif N, Gray RJ, Stucky CH, Northfelt DW, Anderson KS, McCullough AE, Tolgay Ocal I, Pockaj BA.

Am J Surg. 2017 Dec;214(6):1102-1103. doi: 10.1016/j.amjsurg.2017.09.024. Epub 2017 Sep 30. No abstract available.

PMID:
29037421
22.

Discussion of: "Radioactive seed localization for breast conservation surgery: Low positive margin rate with no learning curve".

Velazco CS, Wasif N, Pockaj BA, Gray RJ.

Am J Surg. 2017 Dec;214(6):1094-1095. doi: 10.1016/j.amjsurg.2017.09.026. Epub 2017 Sep 30. No abstract available.

PMID:
28985889
23.

Radioactive seed localization for breast conservation surgery: Low positive margin rate with no learning curve.

Velazco CS, Wasif N, Pockaj BA, Gray RJ.

Am J Surg. 2017 Dec;214(6):1091-1093. doi: 10.1016/j.amjsurg.2017.08.025. Epub 2017 Sep 19.

PMID:
28947271
24.

The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review.

Chang JM, Kosiorek HE, Wasif N, Gray RJ, Stucky CH, Northfelt DW, Anderson KS, McCullough AE, Ocal IT, Pockaj BA.

Am J Surg. 2017 Dec;214(6):1096-1101. doi: 10.1016/j.amjsurg.2017.08.024. Epub 2017 Sep 18.

PMID:
28943062
25.

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.

Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone S 4th, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, Musonza T, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Shah HN, Degnim AC.

Ann Surg Oncol. 2017 Oct;24(10):2915-2924. doi: 10.1245/s10434-017-5927-y. Epub 2017 Aug 1.

PMID:
28766196
26.

Assessing tumor extent on contrast-enhanced spectral mammography versus full-field digital mammography and ultrasound.

Patel BK, Garza SA, Eversman S, Lopez-Alvarez Y, Kosiorek H, Pockaj BA.

Clin Imaging. 2017 Nov - Dec;46:78-84. doi: 10.1016/j.clinimag.2017.07.001. Epub 2017 Jul 12.

PMID:
28750354
27.

Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion.

Patel BK, Naylor ME, Kosiorek HE, Lopez-Alvarez YM, Miller AM, Pizzitola VJ, Pockaj BA.

Clin Imaging. 2017 Nov - Dec;46:44-52. doi: 10.1016/j.clinimag.2017.07.003. Epub 2017 Jul 12.

PMID:
28723585
28.

Potential Cost Savings of Contrast-Enhanced Digital Mammography.

Patel BK, Gray RJ, Pockaj BA.

AJR Am J Roentgenol. 2017 Jun;208(6):W231-W237. doi: 10.2214/AJR.16.17239. Epub 2017 Apr 5.

PMID:
28379734
29.

Clinical Outcomes after Surgery for Linitis Plastica of the Stomach: Analysis of a Population Cancer Registry.

Chang JM, Lara KA, Gray RJ, Pockaj BA, Wasif N.

Am Surg. 2017 Jan 1;83(1):23-29.

PMID:
28234115
30.

Intraoperative Margin Management in Breast-Conserving Surgery: A Systematic Review of the Literature.

Gray RJ, Pockaj BA, Garvey E, Blair S.

Ann Surg Oncol. 2018 Jan;25(1):18-27. doi: 10.1245/s10434-016-5756-4. Epub 2017 Jan 5.

PMID:
28058560
31.

Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center.

Chang JM, Kosiorek HE, Dueck AC, Casey WJ, Rebecca AM, Mahabir R, Patel SH, Keole SR, Wong WW, Vargas CE, Halyard MY, Gray RJ, Wasif N, Stucky CH, Pockaj BA.

Am J Surg. 2016 Dec;212(6):1201-1210. doi: 10.1016/j.amjsurg.2016.08.020. Epub 2016 Sep 29.

PMID:
27866726
32.

Is forgoing chemical venous thromboembolism prophylaxis for women undergoing breast-conserving surgery for breast cancer safe?

Zammar SG, Pockaj BA, Stucky CC, Wasif N, Gray RJ.

Am J Surg. 2016 Dec;212(6):1162-1166. doi: 10.1016/j.amjsurg.2016.09.038. Epub 2016 Oct 3.

PMID:
27773376
33.

Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery.

Ma IT, Gray RJ, Wasif N, Butler KA, Cornella JL, Magrina JF, Magtibay PM, Casey WJ, Mahabir R, Rebecca AM, Hunt KS, Pockaj BA.

Ann Surg Oncol. 2017 Jan;24(1):77-83. doi: 10.1245/s10434-016-5479-6. Epub 2016 Aug 31.

PMID:
27581610
34.

Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma.

Rule WG, Allred JB, Pockaj BA, Markovic SN, DiCaudo DJ, Erickson LA, Deming RL, Schild SE.

Cancer Med. 2016 Aug;5(8):1890-6. doi: 10.1002/cam4.783. Epub 2016 Jul 1.

35.

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes.

Pathangey LB, Lakshminarayanan V, Suman VJ, Pockaj BA, Mukherjee P, Gendler SJ.

Biomolecules. 2016 Jun 29;6(3). pii: E31. doi: 10.3390/biom6030031.

36.

Association of Distance Traveled for Surgery with Short- and Long-Term Cancer Outcomes.

Wasif N, Chang YH, Pockaj BA, Gray RJ, Mathur A, Etzioni D.

Ann Surg Oncol. 2016 Oct;23(11):3444-3452. doi: 10.1245/s10434-016-5242-z. Epub 2016 Apr 28.

PMID:
27126630
37.

Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma.

Mangold AR, Skinner R, Dueck AC, Sekulic A, Pockaj BA.

Dermatol Surg. 2016 May;42(5):646-52. doi: 10.1097/DSS.0000000000000702.

PMID:
27082057
38.

Regional recurrence in the era of sentinel lymph node biopsy.

Linnaus ME, Dueck AC, Kosiorek HE, Gray RJ, Wasif N, Northfelt DW, Anderson KS, McCullough AE, Wong WW, Halyard MY, Patel SH, Pockaj BA.

Am J Surg. 2015 Dec;210(6):1155-60; discussion 1160-1. doi: 10.1016/j.amjsurg.2015.09.001. Epub 2015 Sep 28.

PMID:
26601646
39.

Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry.

Bagaria SP, Wagie AE, Gray RJ, Pockaj BA, Attia S, Habermann EB, Wasif N.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S398-403. doi: 10.1245/s10434-015-4849-9. Epub 2015 Sep 9.

PMID:
26353762
40.

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

Barrett MT, Anderson KS, Lenkiewicz E, Andreozzi M, Cunliffe HE, Klassen CL, Dueck AC, McCullough AE, Reddy SK, Ramanathan RK, Northfelt DW, Pockaj BA.

Oncotarget. 2015 Sep 22;6(28):26483-93. doi: 10.18632/oncotarget.4494.

41.

Validation of a gastric cancer nomogram using a cancer registry.

Ashfaq A, Kidwell JT, McGhan LJ, Dueck AC, Pockaj BA, Gray RJ, Bagaria SP, Wasif N.

J Surg Oncol. 2015 Sep;112(4):377-80. doi: 10.1002/jso.23999. Epub 2015 Aug 14.

PMID:
26271201
42.

Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.

Chang JM, McCullough AE, Dueck AC, Kosiorek HE, Ocal IT, Lidner TK, Gray RJ, Wasif N, Northfelt DW, Anderson KS, Pockaj BA.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S509-15. doi: 10.1245/s10434-015-4616-y. Epub 2015 May 22.

PMID:
26001860
43.

Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA.

PLoS One. 2015 Apr 30;10(4):e0127133. doi: 10.1371/journal.pone.0127133. eCollection 2015. No abstract available.

44.

Rates of residual disease with close but negative margins in breast cancer surgery.

Garvey EM, Senior DA, Pockaj BA, Wasif N, Dueck AC, McCullough AE, Ocal IT, Gray RJ.

Breast. 2015 Aug;24(4):413-7. doi: 10.1016/j.breast.2015.03.005. Epub 2015 Apr 4.

45.

Folate receptor-α (FOLR1) expression and function in triple negative tumors.

Necela BM, Crozier JA, Andorfer CA, Lewis-Tuffin L, Kachergus JM, Geiger XJ, Kalari KR, Serie DJ, Sun Z, Moreno-Aspitia A, O'Shannessy DJ, Maltzman JD, McCullough AE, Pockaj BA, Cunliffe HE, Ballman KV, Thompson EA, Perez EA.

PLoS One. 2015 Mar 27;10(3):e0122209. doi: 10.1371/journal.pone.0122209. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127133. Aspita, Alvaro Moreno [corrected to Moreno-Aspitia, Alvaro].

46.

Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences.

Grotz TE, Joseph RW, Pockaj BA, Foote RL, Otley CC, Bagaria SP, Weaver AL, Jakub JW.

Ann Surg Oncol. 2015 Nov;22(12):4060-6. doi: 10.1245/s10434-015-4421-7. Epub 2015 Feb 13.

PMID:
25676844
47.

Thoracoscopy for internal mammary node dissection of metastatic breast cancer.

Jaroszewski DE, Ewais MM, Pockaj BA.

J Laparoendosc Adv Surg Tech A. 2015 Feb;25(2):135-8. doi: 10.1089/lap.2014.0563. Epub 2014 Dec 23.

PMID:
25535887
48.

Staging studies for cutaneous melanoma in the United States: a population-based analysis.

Wasif N, Etzioni D, Haddad D, Gray RJ, Bagaria SP, Pockaj BA.

Ann Surg Oncol. 2015 Apr;22(4):1366-70. doi: 10.1245/s10434-014-4268-3. Epub 2014 Dec 4.

PMID:
25472650
49.

Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?

Robinson KA, Pockaj BA, Wasif N, Kaufman K, Gray RJ.

Am J Surg. 2014 Dec;208(6):1060-4; discussion 1063-4. doi: 10.1016/j.amjsurg.2014.08.009. Epub 2014 Oct 11.

PMID:
25312842
50.

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.

Reese JM, Suman VJ, Subramaniam M, Wu X, Negron V, Gingery A, Pitel KS, Shah SS, Cunliffe HE, McCullough AE, Pockaj BA, Couch FJ, Olson JE, Reynolds C, Lingle WL, Spelsberg TC, Goetz MP, Ingle JN, Hawse JR.

BMC Cancer. 2014 Oct 7;14:749. doi: 10.1186/1471-2407-14-749.

Supplemental Content

Loading ...
Support Center